A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma
Interventional • Run by National Cancer Institute (NCI)
Recurrent Low Grade Astrocytoma
All Conditions(5)